Skip to main content

RT @ericdeinmd: L15 #ACR22 SURPASS: SEC vs bsADA (SDZ-ADL) on radiographic progression of AS P3b: SEC 150 mg v SEC 300 v

Nov 14, 2022 9:17 am
Social Author Name
Eric Dein
Tweet Content
L15 #ACR22 SURPASS: SEC vs bsADA (SDZ-ADL) on radiographic progression of AS P3b: SEC 150 mg v SEC 300 v SDZ-ADL Wk 104: no radiographic progression in 66%, 67%, 66% - no statistical significance Hard to assess as overall, low rate of progression @RheumNow
Show on Archive Page
On
Display in Search Results
On
PDQ
Off
×